Webform

Sign Up for Our Newsletter!

Stay connected with ZERO Prostate Cancer through our newsletter below:

Name
Banner_Prostate Cancer News

NEED TO FIX --- Dr Neeraj Agarwal on Why PARP Inhibitor Approval in Prostate Cancer Is Slow-Moving

AJMCtv Logo

FDA approvals for PARP inhibitors in prostate cancer treatment have taken longer than in ovarian cancer treatment. Neeraj Agarwal, MD, a professor of medicine, physician, and director of the genitourinary oncology program at the University of Utah’s Huntsman Cancer Institute, discusses the challenges associated with testing and gaining approval of new drugs in prostate cancer.

Read the full article here. 


source: Rose McNulty - AJMC

Read More About Prostate Cancer

Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter.

Share